CSL Licenses Therapeutic Antibodies From Aussie Newcomer Patrys
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Melbourne-based biotech Patrys inked a licensing deal with CSL Limited for several of Patrys' therapeutic monoclonal antibody candidates